T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network

Detalles Bibliográficos
Autores principales: Murray, Sam, Longet, Stephanie, Tipton, Tom, Londoño, Maria Carlota, Pose, Elisa, Laidlaw, Stephen, Nguyen, Dung, Meacham, Georgina, Lim, Zixiang, Dimitriadis, Stavros, Irwin, Sophie, Cook, Jonathan, Iavarone, Massimo, Lampertico, Pietro, Hernandez-Gea, Virginia, Garcia Pagan, Juan Carlos, zur Wiesch, Julian Schulze, Sterneck, Martina, Russo, Francesco Paolo, Satsangi, Jack, Dunachie, Susanna, Klenerman, Paul, Goodyear, Carl, McInnes, Iain B., Ginès, Pere, Carroll, Miles, Marjot, Thomas, Barnes, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
ORAL PRESENTATIONS: Friday 24 June: Liver Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252356/
http://dx.doi.org/10.1016/S0168-8278(22)00518-9

Ejemplares similares

Ejemplares similares